Evaluation of neuroprotective role of benfotiamine in Alzheimer's disease model: A randomized control study.

It can be concluded that oral supplementation of 300mg /kg b.w. /day of BFT may reverse AD pathological processes and improve dementia. However, the need of thiamine supplementation in elderly persons to delay or halt the cognitive loss and eventual dementia needs validation by clinical trial.